B3GAT1 and neoplasm: Suen et al. showed that the clonal expansion of CD8+ TCRVβ+CD57+CD28– T cells, which are thought to be tumor specific, had a lower PD-1 expression compared with CD8+TCRVβ–CD57+ nonclonal T cells, indicating low binding of the anti-PD-1 antibody [101].